Publicacions en què col·labora amb Hanghang Wu (4)

2024

  1. Identification of PRMT5 as a therapeutic target in cholangiocarcinoma

    Gut

2022

  1. Activation of the unfolded protein response (Upr) is associated with cholangiocellular injury, fibrosis and carcinogenesis in an experimental model of fibropolycystic liver disease

    Cancers, Vol. 14, Núm. 1

  2. Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy

    Cell death & disease, Vol. 13, Núm. 2, pp. 143

2021

  1. Fibrotic events in the progression of cholestatic liver disease

    Cells, Vol. 10, Núm. 5